THE EFFECT OF PERIOPERATIVE ADMINISTRATION OF RECOMBINANT HUMAN ERYTHROPOIETIN (r-HuEPO) IN CABG PATIENTS: A DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL